1. Background {#sec1}
=============

Choledochal cyst (CC) is a rare congenital anomaly of the bile duct (BD) [@bib1], for which there is no standardized surgical treatment [@bib2]. Defined as a pathological dilation of the BD [@bib3], [@bib4], if left untreated CC has complications that range from BD obstruction to cholangiocarcinoma [@bib5]. It is estimated that CC has an overall incidence of 1 in 100/150 000 live births in the western population [@bib1], whit a 3--4:1 female predominance, 75% of which are diagnosed in childhood [@bib1], [@bib3].

The treatment of the CC will vary accordingly to the Todani\'s classification ([Table 3](#tbl3){ref-type="table"}) [@bib6]; for the commonest type of Choledochal cyst (Type I and IV) the treatment is surgery, although, the reconstruction technique of the BD has no gold standard [@bib7]. The surgical approach has evolved from drainage procedures to the excision of the cyst and reconstruction of the BD as the treatment of choice [@bib5], [@bib8]. There are two reconstruction techniques, hepaticojejunal anastomosis in Roux-en-Y and hepaticoduodenal anastomosis, with no apparent benefit of any of them.

The present report shows the 15-years experience in the management of the choledochal cyst in the Pediatric Surgery Department of the Hospital Civil de Guadalajara "Dr. Juan I. Menchaca". Our primary end-point was to show the differences in the outcome between the reconstructions of the bile duct techniques in our population.

2. Methods {#sec2}
==========

We did a retrospective, hospital archive search for patients admitted to the pediatric surgery department with the diagnosis of a choledochal cyst from January 2000 to June 2015. We did not require the Ethical approval as long as we did not publish any personal data. We found 15 patients, of which, we excluded one because of missing data from the hospital record. A total of fourteen patients were included; we collected the following data: age at the time of presentation, sex, clinical features, associated congenital anomalies, complementary paraclinical tests, surgical technique used for treatment, complications, hospital length-of-stay and following-up.

The statistical analysis was done by parametric statistics with media, average or range for quantitative variables and percentages for qualitative variables. We use Mann--Whitney U-value, Chi-square and Pearson Correlation as needed.

3. Results {#sec3}
==========

We studied a total of fourteen patients ([Table 1](#tbl1){ref-type="table"}), 71.42% were female (n = 10), and 28.57% were male (n = 4), the female to male ratio was 2.5:1, the average age of presentation was 5.2-years (range from 1 to 15-years). Clinical symptoms varied in a significant manner, the combination of abdominal pain and jaundice was the predominant symptomatology presented in the 64.2% of our population (n = 9, [Table 1](#tbl1){ref-type="table"}). We observed the classic triad of jaundice, abdominal pain and palpable mass only in two patients; also, the association of CC with another congenital anomaly was not seen in our population ([Table 1](#tbl1){ref-type="table"}). Two of our patients (patient 8 and patient 9) had a spontaneous perforation of the CC found as an incidental finding during the laparotomy.

Paraclinical tests showed elevated liver enzymes (AST and ALT) in 92.8% of patients (n = 13), as well as elevated alkaline phosphatase in 100%, and 57.1% had hyperbilirubinemia with an obstructive pattern (n = 8). As a diagnostic approach, abdominal ultrasound was performed on all patients, supporting the CC diagnosis in 42.8% (n = 6). Of the regarding eight patients, four had a CT scan, and two had an MRI, achieving the diagnosis of CC in all the six patients. The other two patients were diagnosed during laparotomy secondary to a CC perforation.

The surgical approach consisted of excision of the cyst in all of the patients; the bile duct reconstruction technique was: hepaticojejunal anastomosis in Roux-en-Y (HY) 57.1% (n = 8) and hepaticoduodenal anastomosis (HD) in 42.9% (n = 6). The general complication rate of the two groups was 21.4%; analyzing separately each group, HY had complications in 25% (n = 2/8), and HD in 16.6% (n = 1/6) respectively, this difference was not statistically significant (P = 0.71). The average hospital length-of-stay (LOS) for the HY group was 19 ± 8.2-days vs. 14 ± 1.6-days for the HD group (no statistical significant). The demographic data are described in [Table 1](#tbl1){ref-type="table"}.

4. Discussion {#sec4}
=============

Choledochal cyst is a rare entity defined as a cystic dilation of the biliary tract [@bib1], [@bib2], [@bib3], its etiology is not well defined, Babbitt DP 1969 [@bib8] theory is the most accepted etiology theory, proposing that an abnormal junction between the biliopancreatic duct (ABPJ) create a shared channel that allows reflux of pancreatic secretion into the biliary tract thus causing increased pressure with subsequent ductal dilation. Further authors have found this association in up to 96% of cases [@bib2], [@bib3], [@bib9], [@bib10], [@bib11]. Other congenital anomalies have been associated with CC like double common bile duct, sclerosing cholangitis, hepatic fibrosis, pancreatic cyst, annular pancreas and cardiac abnormalities [@bib3], [@bib12], [@bib13]. We did not found any congenital anomaly associated with CC in our series ([Table 1](#tbl1){ref-type="table"}); the APBJ was not searched for in our patients.

International literature reports a 3--4:1 female to male ratio with predominance in Asian population [@bib1], [@bib2], [@bib3], [@bib14], however, in Mexican literature this is variable with different authors reporting different proportions. Orozco-Sanchez et al., 1997 [@bib15] reported a 16:1 ratio, Gallardo-Meza et al., 2010 [@bib16] 2:1, Jimenez-Urueta et al., 2013 [@bib17] 3:1, and Palmer-Becerra et al., 2010 [@bib18] 2.5:1. We found a 2.5:1 female to male relation; nevertheless, after adding all the patients of the Mexican series we found a female to male ratio of 2.8:1 which is close to the international literature. Although the Asian population is more affected than any other ethnicity with an incidence of 1 in 1000 live births [@bib1] Wiseman K et al., 2005 [@bib19] reported the largest North America series of CC and did not found any statistically significant difference in the presentation, management, or outcome between Caucasians and Asians. They also found a female to male ratio of 4:1.

The classical clinical triad of jaundice, pain, and a palpable mass can be found in about 20% of cases, with predominance in childhood [@bib1], [@bib3]. We found this triad only in two patients, which makes up for 14.2%. Jaundice and abdominal pain are the most dominant clinical features in children [@bib3], [@bib17], [@bib20], [@bib21], these symptoms were found in our series in 78.5% and 85.7% respectively ([Table 2](#tbl2){ref-type="table"}), and together were found in the 64.2% (n = 9, [Table 1](#tbl1){ref-type="table"}).

Abdominal ultrasound (US) is the cornerstone of diagnostic approach, whose certainty, can reach a correct diagnosis in 50%, with an appropriate CC classification in 30%, this is directly related to the operator\'s experience [@bib3], [@bib22]. Twelve of our patients had an abdominal US, with an accurate diagnosis and classification of the CC (according to Todani), in 40%. The gold standard to define the anatomy of the biliary tract is the contrast intraoperative cholangiography [@bib23]. Non-invasive test to define the anatomy of the biliary tree include computed tomography (about 90% sensibility and specificity), hepatobiliary scintigraphy with Technetium 99 (HIDA) (67--100% sensibility) and magnetic resonance imaging (MRI) (70--100% sensitivity and 90--100% specificity), they can all be used as diagnostic approach, considering MRI as the first line in preoperative diagnosis to define the biliary tract [@bib1], [@bib3], [@bib9]. The MRI has the advantage of simultaneously and effortlessly delineates both the biliary and pancreatic duct and therefore accordingly to the cholangiography morphology classify the images ergo Todani\'s classification [@bib24]. Nonetheless, Acker SN et al., 2013 [@bib25] concluded that preoperative imaging is unable to predict real intrahepatic involvement in CC accurately.

Once the imaging diagnosis is confirmed, we proceed to classify it according to Todanis classification [@bib6] ([Table 3](#tbl3){ref-type="table"}); rendering to this classification, a surgical approach is planned, in this case 9/14 our patients had a preoperative diagnosis of CC type I and 3/14 had a preoperative diagnosis of CC type IV, thus treatment consisted of complete excision, cholecystectomy, and biliary tract reconstruction [@bib1], [@bib3]; the other two patients had the same procedure once we found the CC intraoperatively. Biliary tract reconstruction technique is not standardized, the systematic review and meta-analysis by Narayanan SK et al., 2013 [@bib26] show that there were no statistically significant difference in biliary leak, cholangitis, anastomotic stenosis, surgical re-intervention and postoperative small bowel obstruction, however there was a difference in biliary reflux favoring HY anastomosis, and a shorter hospital stay in patients who underwent HD anastomosis, although there were no randomized clinical trials included in the analysis. We found a shorter hospital LOS in the group of HD, but it was not statistical significant (P = 0.2).

In our cases series, eight HY in Roux-en-Y were performed, two of these patients presented complications, one had repetitive cholangitis secondary to stenosis of the biliary reconstruction and had to undergo biliary reconstruction remodeling ([Table 1](#tbl1){ref-type="table"}), and the other one had a postoperative bleeding that resolve with medical treatment. We did six HD anastomosis with only one patient presenting a stricture of the anastomosis with repetitive episodes of acute cholangitis that required a conversion of the BR into a HY without statistical significant. In México, three of the five reports on CC support the HD biliary reconstruction technique [@bib16], [@bib17], [@bib27], Santore MT et al., 2011 [@bib4] and Elhalaby E et al., 2005 [@bib28] sustenance this information in their retrospective comparative series. Nevertheless, it is thought that there is an increased incidence of biliary reflux with this technique, which also represents an increased risk for cancer development [@bib26], [@bib29]. Todani T et al., 2002 [@bib30] reported a case of hilar bile duct carcinoma developing after 19 years following primary cyst excision and HD for biliary reconstruction; similarly, Onu S et al., 2010 [@bib31] reported on their series of 56 patients two patients with biliary tract malignancy after CC resection, one of them developed after 26-year of the initial resection.

The laparoscopic approach for the management of the Choledochal cyst has not a real contraindication, but enough experience of the surgeon with laparoscopic dissection, suture, and vascular control is needed [@bib32]. The intraoperative and postoperative complications are very similar to the open approach and laparoscopic approach, therefore, many centers has applied the laparoscopic management as the routine procedure [@bib33], [@bib34].

Our study has several limitations, the study was done in a retrospective matter, we have a small number of patients and a relatively short follow-up of the patients with an average of 3.6-years per patient (ranging from 8-month to 15-year); standardized postoperative follow-up is imperative for long-term conclusions. On the other hand, this represents the experience of a single surgeon in a single institution, which dismissed all possible bias in the surgical judgment. None of the authors had any funding to disclosure.

5. Conclusion {#sec5}
=============

Choledochal cyst is a rare disease with surgical treatment well defined (complete excision). However, the surgical technique for biliary tract reconstruction is not established yet. Until now, evidence shows a small advantage for HY anastomosis [@bib26], [@bib35]. Nonetheless, our results although no statistically significant shows an advantage for the HD anastomosis about LOS. Since there are not prospective randomized clinical trials clinical, judgment and experience of the attending surgeon will determine the technique for the biliary tract reconstruction.
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###### 

Demographic data of the patients

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Patient   Age                 Sex   Clinical Symptoms   Todani\   Surgical Technique   Complications   Pathology   LOS days   Following-up                                                                                                                                                                                 
                                                          PreOp                                                                                                                                                                                                                                                              
  --------- ------------------- ----- ------------------- --------- -------------------- --------------- ----------- ---------- -------------- ---- ----------------------------- -------------------------------------------------------------- ------------------------- -------------------------------------------- ---- ----------
  1         4 years             F     Yes                 No        Yes                  No              Yes 2 cm    No         No             1    HD anastomosis                No                                                             Choledochal cyst type 1   NR                                           14   9 months

  2         1 year 8 months     F     No                  Yes       Yes                  Yes             No          No         No             1    HY anastomosis in Roux-en-Y   No                                                             Choledochal cyst type 1   Microvesicular steatosis                     16   6 years

  3         1 year 7 months     F     Yes                 Yes       No                   No              Yes 2 cm    No         No             1    HY anastomosis in Roux-en-Y   No                                                             Choledochal cyst type 1   NR                                           16   13 years

  4         7 years             M     Yes                 Yes       No                   No              Yes 11 cm   No         No             4    HY anastomosis in Roux-en-Y   POp bleeding                                                   Choledochal cyst type 1   Incomplete septal liver cirrhosis            25   11 years

  5         5 years 7 months    F     Yes                 Yes       Yes                  No              No          No         No             1    HD anastomosis                No                                                             Choledochal cyst type 1   Normal                                       12   8 months

  6         1 year 4 months     F     Yes                 Yes       no                   Yes             Yes 3 cm    Yes        Yes            4    HD anastomosis                No                                                             Choledochal cyst type 1   NR                                           14   \-

  7         2 years 11 months   F     Yes                 Yes       Yes                  No              Yes 4 cm    No         No             1    HY anastomosis in Roux-en-Y   2011 stenosis of the anastomosis with remodeling of the BR\    Choledochal cyst type 1   Incomplete septal liver cirrhosis            17   5 years
                                                                                                                                                                                  2013 repetitive grade I cholangitis resolve by antibiotics                                                                                 

  8         3 years             F     Yes                 Yes       Yes                  Yes             No          No         No             NR   HY anastomosis in Roux-en-Y   No                                                             Choledochal cyst type 1   NR                                           12   3 years

  9         1 year 10 months    M     Yes                 Yes       Yes                  No              No          No         No             1    HY anastomosis in Roux-en-Y   No                                                             Choledochal cyst type 1   NR                                           35   3 years

  10        15 years            F     Yes                 No        Yes                  No              No          No         No             NR   HY anastomosis in Roux-en-Y   No                                                             Choledochal cyst type 1   NR                                           13   2 years

  11        2 years 4 months    F     No                  Yes       Yes                  Yes             No          No         No             1    HD anastomosis                No                                                             Choledochal cyst type 1   Grade 2-3 liver fibrosis                     12   8 months

  12        15 years            F     Yes                 Yes       No                   No              No          No         No             1    HY anastomosis in Roux-en-Y   No                                                             Choledochal cyst type 1   NR                                           15   1 year

  13        3 years 8 months    M     Yes                 Yes       Yes                  No              Yes         Yes        Yes            4    HD anastomosis                No                                                             Choledochal cyst type 1   Moderate chronic cholestatic liver disease   14   1 year

  14        8 years             M     Yes                 No        Yes                  No              No          No         No             1    HD anastomosis                2013 stenosis of the BR\                                       Choledochal cyst type 1   Normal                                       16   3 years
                                                                                                                                                                                  2013 remodeling of the BR with a HY anastomosis in Roux-en-Y                                                                               
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**P**=pain, **J**=jaundice, **V**=vomit, **F**=fever, **H**=hepatomegaly, **PM**=palpable mass, **T**=triad, **LOS**=hospital length of stay **PreOp**=preoperative, **NR**=non-referred, **HD**=hepaticoduodenal, **HY**=hepaticojejunal, **CC**=Choledochal cyst, **BR**=biliary reconstruction, **F**=female, **M**=male,

###### 

Clinical features.

  Clinical feature          Patient number   Percentage %
  ------------------------- ---------------- --------------
  Abdominal pain            12/14            85.7
  Jaundice                  11/14            78.5
  Palpable abdominal mass   2/14             14.2
  Vomit                     10/14            71.4
  Fever                     4/14             28.5
  Hepatomegaly              6/14             42.8

###### 

Modified Todani Classification for choledochal cyst.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------
  I                                                                                                                                                                          Cyst limited to the extrahepatic biliary tract. Can be associated with dilation of the intrahepatic duct secondary to biliary stasis.
  IA: Saccular dilation, affecting all or almost all the extrahepatic biliary tree. The gallbladder is originated on the choledochal cyst. Not altered intrahepatic ducts.   
  IB: limited saccular dilation, affecting the distal portion of the choledocus.                                                                                             
  IC: fusiform dilation of the common hepatic duct and the choledocus.                                                                                                       
  II                                                                                                                                                                         Extrahepatic supra-duodenal diverticulum, with a normal gallbladder and common hepatic duct.
  III                                                                                                                                                                        Choledococele: intraduodenal diverticulum
  IV                                                                                                                                                                         Dilated intra and extra hepatic ducts
  IVA: Fusiform extrahepatic duct dilation and intrahepatic cysts                                                                                                            
  IVB Multiple extrahepatic biliary tree dilations, "Pearls Necklace" appearance. No intrahepatic alteration                                                                 
  V                                                                                                                                                                          Multiple intrahepatic cysts, no extrahepatic alteration. When combined with congenital hepatic fibrosis, is called "Caroli Syndrome"
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------
